Vitrolife Overview
- Year Founded
-
1994
- Status
-
Public
- Employees
-
1,088
- Stock Symbol
-
VITR
- Investments
-
16
- Share Price
-
$11.88
- (As of Friday Closing)
Vitrolife General Information
Description
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
Contact Information
Website
www.vitrolifegroup.comCorporate Office
- Gustaf Werners gata 2, 421 32 Västra Frölunda
- PO Box 9080
- 400 92 Göteborg
- Sweden
Corporate Office
- Gustaf Werners gata 2, 421 32 Västra Frölunda
- PO Box 9080
- 400 92 Göteborg
- Sweden
Vitrolife Stock Performance
As of 13-Nov-2026, Vitrolife’s stock price is $11.88. Its current market cap is $1.58B with 133M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $11.88 | $11.82 | $8.64 - $16.07 | $1.58B | 133M | 193K | -$3.90 |
Vitrolife Financials Summary
As of 30-Sep-2026, Vitrolife has a trailing 12-month revenue of $366M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,366,628 | 2,117,409 | 2,748,255 | 2,776,740 |
| Revenue | 365,991 | 350,137 | 341,246 | 330,414 |
| EBITDA | (461,347) | (448,461) | 112,141 | (302,189) |
| Net Income | (527,649) | (510,142) | 48,506 | (362,307) |
| Total Assets | 1,142,539 | 1,208,878 | 1,581,185 | 1,633,890 |
| Total Debt | 172,566 | 174,420 | 189,332 | 209,027 |
Vitrolife Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vitrolife Comparisons
Industry
Financing
Details
Vitrolife Competitors (4)
One of Vitrolife’s 4 competitors is Esco Medical, a Venture Capital-Backed company based in Singapore, Singapore.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Esco Medical | Venture Capital-Backed | Singapore, Singapore | ||||
| Laborie Medical Technologies | Private Equity-Backed | Portsmouth, NH | ||||
| PENTAX Medical | Corporation | Tokyo, Japan | ||||
| Medtronic | Corporation | Minneapolis, MN |
Vitrolife Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vitrolife Patents
Vitrolife Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4733378-A1 | System for selecting spermatozoa | Pending | 26-Jun-2023 | ||
| AU-2023400737-A1 | Fluid conduit holder and associated methods | Pending | 30-Nov-2022 | ||
| EP-4627052-A1 | Fluid conduit holder and associated methods | Pending | 30-Nov-2022 | ||
| GB-202218022-D0 | Fluid conduit holder and associated methods | Inactive | 30-Nov-2022 | ||
| WO-2024115563-A1 | Fluid conduit holder and associated methods | Inactive | 30-Nov-2022 | C12M21/06 |
Vitrolife Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vitrolife Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vitrolife Investments & Acquisitions (16)
Vitrolife’s most recent deal was a Seed Round with AutoIVF for . The deal was made on 08-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AutoIVF | 08-May-2025 | Seed Round | Biotechnology | ||
| eFertility | 17-May-2024 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Igenomix USA | 30-Nov-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Parallabs | 10-May-2019 | Merger/Acquisition | Distributors (Healthcare) | ||
| MTG - Medical Technology Vertriebs | 31-May-2016 | Merger/Acquisition | Distributors/Wholesale |
Vitrolife ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
26.83 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Vitrolife Exits (2)
Vitrolife’s most recent exit was on 26-Jan-2006 from Swemed. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Swemed | 26-Jan-2006 | Completed |
|
||
| Cellartis | 17-Sep-2001 | Early Stage VC | Completed |
|
Vitrolife Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Vitrolife & Igenomix Europe, Part of Vitrolife Group | Guildford, United Kingdom | 2017 | |
| Igenomix USA | Paterna, Spain | 2011 | |
| HertART | Greve Strand, Denmark | 2010 | |
| eFertility | IJsselstein, Netherlands | 2007 | |
| Unisense FertiliTech | Aarhus, Denmark | 2003 |
Vitrolife FAQs
-
When was Vitrolife founded?
Vitrolife was founded in 1994.
-
Where is Vitrolife headquartered?
Vitrolife is headquartered in Göteborg, Sweden.
-
What is the size of Vitrolife?
Vitrolife has 1,088 total employees.
-
What industry is Vitrolife in?
Vitrolife’s primary industry is Laboratory Services (Healthcare).
-
Is Vitrolife a private or public company?
Vitrolife is a Public company.
-
What is Vitrolife’s stock symbol?
The ticker symbol for Vitrolife is VITR.
-
What is the current stock price of Vitrolife?
As of 13-Nov-2026 the stock price of Vitrolife is $11.88.
-
What is the current market cap of Vitrolife?
The current market capitalization of Vitrolife is $1.58B.
-
What is Vitrolife’s current revenue?
The trailing twelve month revenue for Vitrolife is $366M.
-
Who are Vitrolife’s competitors?
Esco Medical, Laborie Medical Technologies, PENTAX Medical, and Medtronic are competitors of Vitrolife.
-
What is Vitrolife’s annual earnings per share (EPS)?
Vitrolife’s EPS for 12 months was -$3.90.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
